P854: EFFECT OF HPSE AND HPSE2 SNPS ON THE RISK OF DEVELOPING PRIMARY PARASKELETAL MULTIPLE MYELOMA

• Olga Ostrovsky,
• Katia Beider,
• Hila Magen,
• Merav Leiba,
• Israel Vlodavsky,
• Arnon Nagler

Affiliations

Olga Ostrovsky

1 Chaim Sheba Medical Center, Department of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel

Katia Beider

1 Chaim Sheba Medical Center, Department of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel

Hila Magen

1 Chaim Sheba Medical Center, Department of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel

Merav Leiba

1 Chaim Sheba Medical Center, Department of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel

Israel Vlodavsky

2 Technion, Technion Integrated Cancer Center (TICC), Rappaport Faculty of Medicine, Haifa, Israel

Arnon Nagler

1 Chaim Sheba Medical Center, Department of Hematology and Bone Marrow Transplantation, Ramat Gan, Israel